Source: Europace. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), MORTE SÚBITA CARDÍACA (PREVENÇÃO E CONTROLE), DESFIBRILADORES, TAQUICARDIA VENTRICULAR, ÍNDICE DE GRAVIDADE DA DOENÇA
ABNT
GALI, Wagner L et al. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Europace, v. 16, n. 5, p. 674-680, 2014Tradução . . Disponível em: https://doi.org/10.1093/europace/eut422. Acesso em: 07 jul. 2024.APA
Gali, W. L., Sarabanda, A. V., Baggio, J. M., Ferreira, L. G., Gomes, G. G., Marin Neto, J. A., & Junqueira, L. F. (2014). Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Europace, 16( 5), 674-680. doi:10.1093/europace/eut422NLM
Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin Neto JA, Junqueira LF. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone [Internet]. Europace. 2014 ; 16( 5): 674-680.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1093/europace/eut422Vancouver
Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin Neto JA, Junqueira LF. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone [Internet]. Europace. 2014 ; 16( 5): 674-680.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1093/europace/eut422